Impacto da infecção por COVID-19 em pacientes com doenças reumáticas autoimunes
DOI:
https://doi.org/10.34119/bjhrv6n1-165Keywords:
doenças reumáticas, doenças autoimunes, COVID-19, fatores de riscoAbstract
Objetivo: Descrever o impacto da infecção por COVID-19 em pacientes com doenças reumáticas autoimunes. Metodologia: Foi realizado um estudo descritivo não experimental do tipo revisão de literatura, utilizando artigos de pesquisa indexados publicados nos últimos 3 anos, em espanhol e inglês, em bancos de dados como o PubMed e Web of Science. Para a consulta nos diferentes mecanismos de busca, foram utilizadas palavras-chave como agente reumatológico, doenças autoimunes, COVID-19, doença reumática. Resultados: A infecção por COVID-19 em pacientes com doenças reumáticas autoimunes não é diferente da população em geral, e foi até mesmo demonstrado que existe um menor risco de infecção e doença infecciosa grave devido ao uso de drogas que reduzem a resposta sistêmica. Da mesma forma, a presença de comorbidades, o uso de corticosteroides ou rituximabe influenciam o curso clínico. Conclusões: O impacto da infecção COVID-19 em pessoas diagnosticadas com doença reumática autoimune são tão prováveis de serem infectadas quanto a população em geral. Foi até mesmo demonstrado que existe um risco reduzido de infecção e doenças infecciosas graves devido ao uso de drogas que reduzem a resposta sistêmica. Os principais sintomas encontrados foram febre, tosse, calafrios e dispneia.
References
Akiyama, S., Hamdeh, S., Micic, D., & Sakuraba, A. (2020). Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: A systematic review and meta-analysis. Annals of the Rheumatic Diseases, annrheumdis-2020-218946. https://doi.org/10.1136/annrheumdis-2020-218946
Alzahrani, Z. A., Alghamdi, K. A., & Almaqati, A. S. (2021). Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases. Rheumatology International, 41(6), 1097-1103. https://doi.org/10.1007/s00296-021-04857-9
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2021). Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management. Scandinavian Journal of Immunology, 93(4), e12998. https://doi.org/10.1111/sji.12998
Assar, S., Mohamadzadeh, D., Pournazari, M., & Soufivand, P. (2022). Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases. EGYPTIAN RHEUMATOLOGIST, 44(3), 209-213. https://doi.org/10.1016/j.ejr.2021.12.002
Ayala Gutierrez, M. del M., Rubio-Rivas, M., Romero Gomez, C., Montero Saez, A., Perez de Pedro, I., Homs, N., Ayuso Garcia, B., Cuenca Carvajal, C., Arnalich Fernandez, F., Beato Perez, J. L., Vargas Nunez, J. A., Letona Gimenez, L., Suarez Fernandez, C., Mendez Bailon, M., Tunon de Almeida, C., Gonzalez Moraleja, J., de Guzman Garcia-Monge, M., Helguera Amezua, C., Fidalgo Montero, M. del P., … Network, S. C.-19. (2021). Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry. JOURNAL OF CLINICAL MEDICINE, 10(9). https://doi.org/10.3390/jcm10091844
Bachiller-Corral, J., Boteanu, A., Garcia-Villanueva, M., de la Puente, C., Revenga, M., Diaz-Miguel, M., Rodriguez-Garcia, A., Morell-Hita, J., Valero, M., Larena, C., Blazquez-Canamero, M., Guillen-Astete, C., Garrote, S., Sobrino, C., Medina-Quinones, C., & Vazquez-Diaz, M. (2021). Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases. JOURNAL OF RHEUMATOLOGY, 48(7), 1098-1102. https://doi.org/10.3899/jrheum.200755
Bakasis, A.-D., Mavragani, C. P., Boki, K. A., Tzioufas, A. G., Vlachoyiannopoulos, P. G., Stergiou, I. E., Skopouli, F. N., & Moutsopoulos, H. M. (2021). COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review. Journal of Autoimmunity, 123, 102687. https://doi.org/10.1016/j.jaut.2021.102687
Cordeiro, A. P., Azevedo, P. S., Cruz-Cazarim, E. L. C. da, Silva, D. S. da, Nunes, A. A., Mendonça, A. É. de, Silvério, M. S., & Cazarim, M. de S. (2022). Clinical characteristics and risk for severe COVID-19: A systematic review: Características clínicas e risco para COVID-19 grave: uma revisão sistemática. Brazilian Journal of Health Review, 5(6), 22335-22358. https://doi.org/10.34119/bjhrv5n6-042
D’Silva, K. M., & Wallace, Z. S. (2021). COVID-19 and Disease-Modifying Anti-rheumatic Drugs. Current Rheumatology Reports, 23(5), 28. https://doi.org/10.1007/s11926-021-00998-9
Esalatmanesh, K., Azadbakht, J., Hajialilo, M., Soroush, M., Esalatmanesh, R., Soleimani, Z., & Khabbazi, A. (2022). Clinical course, chest computed tomography severity score and outcome of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases. The Egyptian Rheumatologist, 44(3), 245-250. https://doi.org/10.1016/j.ejr.2021.12.010
Eviatar, T., Elalouf, O., Furer, V., Goldstein-Lahat, Y., Paran, Y., Pel, S., Nevo, S., Zisapel, M., Alcalay, Y., & Elkayam, O. (2021). Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel. INTERNAL MEDICINE JOURNAL, 51(5), 682-690. https://doi.org/10.1111/imj.15202
Favalli, E. G., Biggioggero, M., & Meroni, P. L. (2014). Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an «anchor» drug? Autoimmunity Reviews, 13(11), 1102-1108. https://doi.org/10.1016/j.autrev.2014.08.026
Favalli, E. G., Bugatti, S., Klersy, C., Biggioggero, M., Rossi, S., De Lucia, O., Bobbio-Pallavicini, F., Murgo, A., Balduzzi, S., Caporali, R., & Montecucco, C. (2020). Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Research & Therapy, 22(1), 290. https://doi.org/10.1186/s13075-020-02395-6
Ferri, C., Giuggioli, D., Raimondo, V., L’Andolina, M., Dagna, L., Tavoni, A., Caso, F., Ursini, F., Ruscitti, P., Caminiti, M., Foti, R., Riccieri, V., Guiducci, S., Pellegrini, R., Zanatta, E., Varcasia, G., Olivo, D., Gigliotti, P., Cuomo, G., … Antonelli, A. (2021). Covid-19 and Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. CURRENT PHARMACEUTICAL DESIGN, 27(41), 4245-4252. https://doi.org/10.2174/1381612827666210903103935
Freites Nunez, D. D., Leon, L., Mucientes, A., Rodriguez-Rodriguez, L., Font Urgelles, J., Madrid Garcia, A., Colomer, J., I., Jover, J. A., Fernandez-Gutierrez, B., & Abasolo, L. (2020). Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. ANNALS OF THE RHEUMATIC DISEASES, 79(11), 1393-1399. https://doi.org/10.1136/annrheumdis-2020-217984
Gianfrancesco, M. A., Hyrich, K. L., Gossec, L., Strangfeld, A., Carmona, L., Mateus, E. F., Sufka, P., Grainger, R., Wallace, Z., Bhana, S., Sirotich, E., Liew, J., Hausmann, J. S., Costello, W., Robinson, P., Machado, P. M., & Yazdany, J. (2020). Rheumatic disease and COVID-19: Initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology, 2(5), e250-e253. https://doi.org/10.1016/S2665-9913(20)30095-3
Gianfrancesco, M., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson-Tovey, S., Mateus, E. F., Rush, S., Schmajuk, G., Simard, J., Strangfeld, A., Trupin, L., Wysham, K. D., Bhana, S., Costello, W., … Robinson, P. C. (2020). Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, annrheumdis-2020-217871. https://doi.org/10.1136/annrheumdis-2020-217871
Gracia, B. D. C., Sáez, L., Pallarés, L., Velilla, J., Marín, A., Martinez-Lostao, L., Simeón, C. P., & Fanlo, P. (2022). COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases. Frontiers in Medicine, 8, 808608. https://doi.org/10.3389/fmed.2021.808608
Grainger, R., Kim, A. H. J., Conway, R., Yazdany, J., & Robinson, P. C. (2022). COVID-19 in people with rheumatic diseases: Risks, outcomes, treatment considerations. Nature Reviews. Rheumatology, 18(4), 191-204. https://doi.org/10.1038/s41584-022-00755-x
Grange, L., Guilpain, P., Truchetet, M.-E., & Cracowski, J.-L. (2020). Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review. Therapie, 75(4), 335-342. https://doi.org/10.1016/j.therap.2020.06.013
Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research, 7(1), 11. https://doi.org/10.1186/s40779-020-00240-0
Haberman, R., Axelrad, J., Chen, A., Castillo, R., Yan, D., Izmirly, P., Neimann, A., Adhikari, S., Hudesman, D., & Scher, J. U. (2020). Covid-19 in Immune-Mediated Inflammatory Diseases—Case Series from New York. The New England Journal of Medicine, NEJMc2009567. https://doi.org/10.1056/NEJMc2009567
Hyrich, K. L., & Machado, P. M. (2021). Rheumatic disease and COVID-19: Epidemiology and outcomes. Nature Reviews. Rheumatology, 17(2), 71-72. https://doi.org/10.1038/s41584-020-00562-2
Kastritis, E., Kitas, G. D., Vassilopoulos, D., Giannopoulos, G., Dimopoulos, M. A., & Sfikakis, P. P. (2020). Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatology International, 40(9), 1353-1360. https://doi.org/10.1007/s00296-020-04629-x
Kawano, Y., Patel, N. J., Wang, X., Cook, C. E., Vanni, K. M., Kowalski, E. N., Banasiak, E. P., Qian, G., DiIorio, M., Hsu, T. Y.-T., Weinblatt, M. E., Todd, D. J., Wallace, Z. S., & Sparks, J. A. (2022). Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave through the initial Omicron wave. Annals of the Rheumatic Diseases, ard-2022-222954. https://doi.org/10.1136/ard-2022-222954
Khan, M., Adil, S. F., Alkhathlan, H. Z., Tahir, M. N., Saif, S., Khan, M., & Khan, S. T. (2020). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26(1), 39. https://doi.org/10.3390/molecules26010039
Marques, C. D. L., Kakehasi, A. M., Pinheiro, M. M., Mota, L. M. H., Albuquerque, C. P., Silva, C. R., Santos, G. P. J., Reis-Neto, E. T., Matos, P., Devide, G., Dantas, A., Giorgi, R. D., Omura, F., Marinho, A. de O., Valadares, L. D. A., Melo, A. K. G., Ribeiro, F. M., Ferreira, G. A., Santos, F. P. de S., … Reis, A. P. M. G. (2021). High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: First results of ReumaCoV Brasil registry. RMD Open, 7(1), e001461. https://doi.org/10.1136/rmdopen-2020-001461
Mikuls, T. R., Johnson, S. R., Fraenkel, L., Arasaratnam, R. J., Baden, L. R., Bermas, B. L., Chatham, W., Cohen, S., Costenbader, K., Gravallese, E. M., Kalil, A. C., Weinblatt, M. E., Winthrop, K., Mudano, A. S., Turner, A., & Saag, K. G. (2021). American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis & Rheumatology (Hoboken, N.J.), 73(2), e1-e12. https://doi.org/10.1002/art.41596
Montero, F., Martinez-Barrio, J., Serrano-Benavente, B., Gonzalez, T., Rivera, J., Collada, J., Castrejon, I., & Alvaro-Gracia, J. (2020). Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: Clinical characteristics of poor outcomes. RHEUMATOLOGY INTERNATIONAL, 40(10), 1593-1598. https://doi.org/10.1007/s00296-020-04676-4
Nader, T. O., Dellalibera, E., & Dellalibera-Joviliano, R. (2023). Covid-19: O papel das Citocinas IL-1, IL-6 e TNF-α na resposta inflamatória. Brazilian Journal of Health Review, 6(1), 225-256. https://doi.org/10.34119/bjhrv6n1-021
Pablos, J., Galindo, M., Carmona, L., Lled, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M., Martinez-Lopez, D., Castrejon, I., Alvaro-Gracia, J., Fernandez, D., Mera-Varela, A., Manrique-Arija, S., Vazquez, N., Fernandez-Nebro, A., & RIER Investigators Grp. (2020). Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study. ANNALS OF THE RHEUMATIC DISEASES, 79(12), 1544-1549. https://doi.org/10.1136/annrheumdis-2020-218296
Pablos, J. L., Abasolo, L., Alvaro-Gracia, J. M., Blanco, F. J., Blanco, R., Castrejón, I., Fernandez-Fernandez, D., Fernandez-Gutierrez, B., Galindo-Izquierdo, M., Gonzalez-Gay, M. A., Manrique-Arija, S., Mena Vázquez, N., Mera Varela, A., Retuerto, M., & Seijas-Lopez, A. (2020). Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Annals of the Rheumatic Diseases, 79(9), 1170-1173. https://doi.org/10.1136/annrheumdis-2020-217763
Pang, R., Zhao, J., Gan, Z., Hu, Z., Xue, X., Wu, Y., Qiao, Q., Zhong, A., Xia, X., Liao, H., Wang, Z., & Zhang, L. (2020). Evolution of COVID-19 in patients with autoimmune rheumatic diseases. Aging, 12(23), 23427-23435. https://doi.org/10.18632/aging.202193
Rommasi, F., Nasiri, M. J., & Mirsaeidi, M. (2022). Immunomodulatory agents for COVID-19 treatment: Possible mechanism of action and immunopathology features. Molecular and Cellular Biochemistry, 477(3), 711-726. https://doi.org/10.1007/s11010-021-04325-9
Ruscitti, P., Conforti, A., Cipriani, P., Giacomelli, R., Tasso, M., Costa, L., & Caso, F. (2021). Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Advances in Rheumatology (London, England), 61(1), 45. https://doi.org/10.1186/s42358-021-00204-5
Schreiber, K., & Hendricks, O. (2021). First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea. The Lancet. Rheumatology, 3(10), e673-e675. https://doi.org/10.1016/S2665-9913(21)00213-7
Schulze-Koops, H., Specker, C., Iking-Konert, C., Holle, J., Moosig, F., & Krueger, K. (2020). Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Annals of the Rheumatic Diseases, 79(6), 840-842. https://doi.org/10.1136/annrheumdis-2020-217628
Shin, J. I., Kim, S. E., Lee, M. H., Kim, M. S., Lee, S. W., Park, S., Shin, Y. H., Yang, J. W., Song, J. M., Moon, S. Y., Kim, S. Y., Park, Y., Suh, D. I., Yang, J. M., Cho, S. H., Jin, H. Y., Hong, S. H., Won, H.-H., Kronbichler, A., … Smith, L. (2022). COVID-19 susceptibility and clinical outcomes in autoimmune inflammatory rheumatic diseases (AIRDs): A systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences, 26(10), 3760-3770. https://doi.org/10.26355/eurrev_202205_28873
Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., Scirè, C. A., Sirotich, E., Sparks, J. A., Sufka, P., Thomas, T., Trupin, L., Wallace, Z. S., Al-Adely, S., Bachiller-Corral, J., … Alliance, C.-19 G. R. (2021). Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, 80(7), 930. https://doi.org/10.1136/annrheumdis-2020-219498
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069. https://doi.org/10.1001/jama.2020.1585
Wang, F., Ma, Y., Xu, S., Liu, H., Chen, Y., Yang, H., Shao, M., Xu, W., Kong, J., Chen, L., Xu, S., Shuai, Z., & Pan, F. (2022). Prevalence and risk of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis. Clinical Rheumatology, 41(7), 2213-2223. https://doi.org/10.1007/s10067-022-06087-1
Wang, Q., Liu, J., Shao, R., Han, X., Su, C., & Lu, W. (2021). Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: A systematic review and meta-analysis. Rheumatology International, 41(5), 851-861. https://doi.org/10.1007/s00296-021-04803-9
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., Zhang, X., Pan, A., & Wei, H. (2020). Effective treatment of severe COVID-19 patients with tocilizumab. Proceedings of the National Academy of Sciences of the United States of America, 117(20), 10970-10975. https://doi.org/10.1073/pnas.2005615117
Yousefghahari, B., Navari, S., Sadeghi, M., Soleimaniamiri, S., Soleimaniamiri, M., Heidari, B., Babaei, M., Ghodrati, K., Guran, A., & Gholinia, H. (2021). Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs. CLINICAL RHEUMATOLOGY, 40(10), 4309-4315. https://doi.org/10.1007/s10067-021-05779-4
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727-733. https://doi.org/10.1056/NEJMoa2001017
Zhu, Y., Zhong, J., & Dong, L. (2021). Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review. Frontiers in Medicine, 8, 725226. https://doi.org/10.3389/fmed.2021.725226
